MECOM and acute myeloid leukemia: Moreover, gene expression analyses demonstrated a stem cell phenotype in EVI1-overexpressing acute myelocytic leukemia cells, suggesting that this oncoprotein could augment cancer stem cell self-renewal capacity and facilitate disease progression and the development of therapeutic resistance [36].